Martina Rella
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Martina Rella has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Angelo Cignarelli
Department of Precision and Regenerative Medicine and Ionian Area-Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, 70121 Bari, Italy
1 shared publication Anna Borrelli
Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy
1 shared publicationAnna Signorile
Department of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, Bari, Italy
1 shared publication- Annalisa Natalicchio
Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases University of Bari Aldo Moro Bari Italy
1 shared publication Antonio Moretti
Institute of Sciences of Food Production, National Research Council of Italy, (CNR-ISPA), Bari, Italy
1 shared publicationCristina Caccioppoli
Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy
1 shared publication
Latest Publications
- Open Access
- 5 June 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (23) , eaee4804
The myokine irisin ameliorates the secretory dysfunction of pancreatic β cells in experimental and human type 2 diabetes
Irisin is a myokine that enhances insulin secretion and β cell viability in both rodent and human β cells. Here, we investigated whether irisin preserves β cell functional mass in vivo in diabetic mice and ex vivo in human pancreatic islets from subjects with type 2 diabetes (T2D). In mice made diabetic by a high-fat diet and streptozotocin, irisin administration improved glycemic homeostasis by increasing islet insulin content and glucose-stimulated insulin secretion while also markedly stimulating β cell proliferation. In islets from T2D subjects, which typically display substantial structural and functional impairments, irisin restored insulin content and glucose-stimulated insulin secretion. Mechanistic studies in INS-1E cells showed that chronic exposure to high glucose blunted glucose-triggered cytoplasmic calcium increases, essential for insulin secretion. Under these glucotoxic conditions, while irisin was unable to activate CREB and AKT, it induced AMPK-mTORC1-S6K–dependent mobilization of endoplasmic reticulum calcium stores, resulting in enhancement of insulin secretion. Overall, these findings highlight irisin’s multifaceted ability to counteract β cell failure in experimental and human T2D.
- 5 June 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (23) , eaee4804
Open AccessThe myokine irisin ameliorates the secretory dysfunction of pancreatic β cells in experimental and human type 2 diabetes
Irisin is a myokine that enhances insulin secretion and β cell viability in both rodent and human β cells. Here, we investigated whether irisin preserves β cell functional mass in vivo in diabetic mice and ex vivo in human pancreatic islets from subjects with type 2 diabetes (T2D). In mice made diabetic by a high-fat diet and streptozotocin, irisin administration improved glycemic homeostasis by increasing islet insulin content and glucose-stimulated insulin secretion while also markedly stimulating β cell proliferation. In islets from T2D subjects, which typically display substantial structural and functional impairments, irisin restored insulin content and glucose-stimulated insulin secretion. Mechanistic studies in INS-1E cells showed that chronic exposure to high glucose blunted glucose-triggered cytoplasmic calcium increases, essential for insulin secretion. Under these glucotoxic conditions, while irisin was unable to activate CREB and AKT, it induced AMPK-mTORC1-S6K–dependent mobilization of endoplasmic reticulum calcium stores, resulting in enhancement of insulin secretion. Overall, these findings highlight irisin’s multifaceted ability to counteract β cell failure in experimental and human T2D.